| Literature DB >> 27551698 |
Abstract
The anti-tumor necrosis factor (TNF)-α agents represent the second generation of psoriasis therapy. Research has produced a third generation of biologic treatments, some of which offer greater efficacy than the TNF-α inhibitors. This article reviews the data documenting the efficacy and safety of three types of biologics.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27551698
Source DB: PubMed Journal: Semin Cutan Med Surg ISSN： 1085-5629